Skip to main content
Erschienen in: Gastric Cancer 2/2019

01.03.2019 | Original Article

Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection

verfasst von: Tae-Se Kim, Byung-Hoon Min, Kyoung-Mee Kim, Jun Haeng Lee, Poong-Lyul Rhee, Jae J. Kim

Erschienen in: Gastric Cancer | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The previous studies demonstrated aggressive clinicopathologic features of papillary early gastric cancer (EGC). This raised concerns about the appropriateness of current Japanese guidelines that recommend the same endoscopic submucosal dissection (ESD) criteria for papillary EGC as for well-differentiated (WD) or moderately differentiated (MD) EGCs.

Methods

This study included 4140 patients who underwent ESD for differentiated-type EGC (87 papillary EGCs and 4259 WD or MD EGCs). The clinicopathologic characteristics and short- and long-term outcomes of ESD for papillary EGC were reviewed and compared with those for WD or MD EGC.

Results

Papillary EGCs were larger, and had higher lymphovascular and submucosal invasion rates than WD or MD EGCs. Lateral resection margin involvement and histological heterogeneity were found more frequently in papillary EGC than in WD or MD EGC. En bloc with R0 resection and curative resection rates of papillary EGC were 85.1 and 49.4%, respectively, and both were significantly lower than those of WD or MD EGC (93.0 and 82.2%). In mucosal cancers, curative resection rates of papillary EGC and WD or MD EGC were 72.5 and 93.7%, respectively. Among patients undergoing curative ESD for papillary EGC, no extra-gastric recurrences occurred during median 58 months of follow-up. Metachronous recurrence occurred in 5.2% of cases.

Conclusions

Given the favorable long-term outcomes after curative resection, ESD might be indicated for papillary EGC according to the current Japanese guidelines. As papillary EGC has considerable lymphovascular and submucosal invasion rates, careful histological examination is required to accurately determine whether curative ESD is achieved.
Literatur
1.
Zurück zum Zitat Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef
2.
Zurück zum Zitat Sekiguchi M, Sekine S, Oda I, Nonaka S, Suzuki H, Yoshinaga S, et al. Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer. J Gastroenterol. 2013;48:706–12.CrossRefPubMed Sekiguchi M, Sekine S, Oda I, Nonaka S, Suzuki H, Yoshinaga S, et al. Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer. J Gastroenterol. 2013;48:706–12.CrossRefPubMed
3.
Zurück zum Zitat Lee HJ, Kim GH, Park DY, Lee BE, Jeon HK, Jhi JH, et al. Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach? World J Gastroenterol. 2015;21:3944–52.CrossRefPubMedPubMedCentral Lee HJ, Kim GH, Park DY, Lee BE, Jeon HK, Jhi JH, et al. Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach? World J Gastroenterol. 2015;21:3944–52.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sekiguchi M, Kushima R, Oda I, Suzuki H, Taniguchi H, Sekine S, et al. Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers. J Gastroenterol. 2015;50:424–34.CrossRefPubMed Sekiguchi M, Kushima R, Oda I, Suzuki H, Taniguchi H, Sekine S, et al. Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers. J Gastroenterol. 2015;50:424–34.CrossRefPubMed
5.
Zurück zum Zitat Lee HJ, Kim GH, Park DY, Kim YK, Jeon HK, Lee BE, et al. Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe? Gastric Cancer. 2017;20:978–86.CrossRefPubMed Lee HJ, Kim GH, Park DY, Kim YK, Jeon HK, Lee BE, et al. Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe? Gastric Cancer. 2017;20:978–86.CrossRefPubMed
6.
Zurück zum Zitat Yu H, Fang C, Chen L, Shi J, Fan X, Zou X, et al. Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer. 2017;8:117–23.CrossRefPubMedPubMedCentral Yu H, Fang C, Chen L, Shi J, Fan X, Zou X, et al. Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer. 2017;8:117–23.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Min BH, Byeon SJ, Lee JH, Kim KM, An JY, Choi MG, et al. Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection. Gastric Cancer. 2018;21:680–8.CrossRefPubMed Min BH, Byeon SJ, Lee JH, Kim KM, An JY, Choi MG, et al. Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection. Gastric Cancer. 2018;21:680–8.CrossRefPubMed
8.
Zurück zum Zitat Min BH, Kim ER, Kim KM, Park CK, Lee JH, Rhee PL, et al. Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer. Endoscopy. 2015;47:784–93.CrossRefPubMed Min BH, Kim ER, Kim KM, Park CK, Lee JH, Rhee PL, et al. Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer. Endoscopy. 2015;47:784–93.CrossRefPubMed
9.
Zurück zum Zitat Pyo JH, Lee H, Min BH, Lee JH, Choi MG, Lee JH, et al. Long-term outcome of endoscopic resection vs. surgery for early gastric cancer: a non-inferiority-matched cohort study. Am J Gastroenterol. 2016;111:240–9.CrossRefPubMed Pyo JH, Lee H, Min BH, Lee JH, Choi MG, Lee JH, et al. Long-term outcome of endoscopic resection vs. surgery for early gastric cancer: a non-inferiority-matched cohort study. Am J Gastroenterol. 2016;111:240–9.CrossRefPubMed
10.
Zurück zum Zitat Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol. 2006;41:929–42.CrossRefPubMed Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol. 2006;41:929–42.CrossRefPubMed
11.
Zurück zum Zitat Lauwers GY, Carneiro F, Graham DY, Curado MP, Franceschi S, Montgomery E, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC; 2010. pp. 48–58. Lauwers GY, Carneiro F, Graham DY, Curado MP, Franceschi S, Montgomery E, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC; 2010. pp. 48–58.
12.
Zurück zum Zitat Kim WH, Park CK, Kim YB, Kim YW, Kim HG, Bae HI. A standardized pathology report for gastric cancer. Korean J Pathol. 2005;39:106–13. Kim WH, Park CK, Kim YB, Kim YW, Kim HG, Bae HI. A standardized pathology report for gastric cancer. Korean J Pathol. 2005;39:106–13.
13.
Zurück zum Zitat Adachi Y, Mori M, Maehara Y, Sugimachi K. Poorly differentiated medullary carcinoma of the stomach. Cancer. 1992;70:1462–6.CrossRefPubMed Adachi Y, Mori M, Maehara Y, Sugimachi K. Poorly differentiated medullary carcinoma of the stomach. Cancer. 1992;70:1462–6.CrossRefPubMed
14.
Zurück zum Zitat Yasuda K, Adachi Y, Shiraishi N, Maeo S, Kitano S. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.CrossRefPubMed Yasuda K, Adachi Y, Shiraishi N, Maeo S, Kitano S. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.CrossRefPubMed
15.
Zurück zum Zitat Min BH, Kim KM, Park CK, Lee JH, Rhee PL, Rhee JC, et al. Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity. Gastric Cancer. 2015;18:618–26.CrossRefPubMed Min BH, Kim KM, Park CK, Lee JH, Rhee PL, Rhee JC, et al. Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity. Gastric Cancer. 2015;18:618–26.CrossRefPubMed
Metadaten
Titel
Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection
verfasst von
Tae-Se Kim
Byung-Hoon Min
Kyoung-Mee Kim
Jun Haeng Lee
Poong-Lyul Rhee
Jae J. Kim
Publikationsdatum
01.03.2019
Verlag
Springer Singapore
Erschienen in
Gastric Cancer / Ausgabe 2/2019
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-018-0857-3

Weitere Artikel der Ausgabe 2/2019

Gastric Cancer 2/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.